David K. Ornstein

5.7k total citations
111 papers, 3.9k citations indexed

About

David K. Ornstein is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, David K. Ornstein has authored 111 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 43 papers in Molecular Biology and 25 papers in Surgery. Recurrent topics in David K. Ornstein's work include Prostate Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Treatment and Research (32 papers) and Renal cell carcinoma treatment (23 papers). David K. Ornstein is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Treatment and Research (32 papers) and Renal cell carcinoma treatment (23 papers). David K. Ornstein collaborates with scholars based in United States, Japan and China. David K. Ornstein's co-authors include William J. Catàlona, Emanuel F. Petricoin, Deborah S. Smith, C.K. Naughton, Michael R. Emmert‐Buck, John W. Gillespie, Darren R. Tyson, Gerald L. Andriole, Cloud P. Paweletz and Paul H. Duray and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

David K. Ornstein

107 papers receiving 3.8k citations

Peers

Countries citing papers authored by David K. Ornstein

Since Specialization

Citations

This map shows the geographic impact of David K. Ornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Ornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Ornstein more than expected).

Fields of papers citing papers by David K. Ornstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Ornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Ornstein. The network helps show where David K. Ornstein may publish in the future.

Co-authorship network of co-authors of David K. Ornstein

This figure shows the co-authorship network connecting the top 25 collaborators of David K. Ornstein. A scholar is included among the top collaborators of David K. Ornstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. Ornstein. David K. Ornstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols 2010 ·World Journal of Urology ·Michael A. Liss, Rosanne Santos, Kathryn Osann, Alice Lau, Thomas E. Ahlering, David K. Ornstein	25
2	Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma 2009 ·Journal of Robotic Surgery ·(unknown), Jennifer L. Young, Atreya Dash, Jose Benito A. Abraham, Geoffrey N. Box, David K. Ornstein	7
3	Positive surgical margins during robotic radical prostatectomy: a contemporary analysis of risk factors 2008 ·British Journal of Urology ·Michael A. Liss, Kathryn Osann, David K. Ornstein	55
4	Annexin A2 positively contributes to the malignant phenotype and secretion of IL‐6 in DU145 prostate cancer cells 2008 ·International Journal of Cancer ·Junichi Inokuchi, Navneet Narula, David S. Yee, Douglas Skarecky, Alice Lau, David K. Ornstein, Darren R. Tyson	55
5	Proteomics of Cancer of Hormone-Dependent Tissues 2008 ·Advances in experimental medicine and biology ·Darren R. Tyson, David K. Ornstein	7
6	Repair of Rectal Injury During Robotic-Assisted Laparoscopic Prostatectomy 2008 ·Urology ·David S. Yee, David K. Ornstein	23
7	Proteomics for the identification of new prostate cancer biomarkers 2006 ·Urologic Oncology Seminars and Original Investigations ·David K. Ornstein, Darren R. Tyson	36
8	Clinical proteomics: Applications for prostate cancer biomarker discovery and detection 2004 ·Urologic Oncology Seminars and Original Investigations ·Emanuel F. Petricoin, David K. Ornstein, Lance A. Liotta	47
9	, J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn. IARC Press, Lyon, France (20045), 359 pages 2004 ·The Journal of Urology ·David K. Ornstein	2
10	How to improve prostate biopsy detection of prostate cancer 2001 ·Current Urology Reports ·David K. Ornstein, John Kang	11
11	PAIN AND MORBIDITY OF TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY: A PROSPECTIVE RANDOMIZED TRIAL OF 6 VERSUS 12 CORES 2000 ·The Journal of Urology ·C.K. Naughton, David K. Ornstein, Deborah S. Smith, William J. Catàlona	155
12	Geographic Variation in Patient Surveillance After Radical Prostatectomy 2000 ·Annals of Surgical Oncology ·(unknown), (unknown), Katherine S. Virgo, (unknown), Danny Chan, John W. Colberg, David K. Ornstein, Frank E. Johnson	8
13	Prostate-specific antigen 2000 ·Expert Opinion on Pharmacotherapy ·David K. Ornstein, Raj S. Pruthi	26
14	The age of the urologist affects the postoperative care of prostate carcinoma patients 1999 ·Cancer ·(unknown), Katherine S. Virgo, John W. Colberg, David K. Ornstein, Eric T. Johnson, Danny Chan, Frank E. Johnson	0
15	CURRENT FOLLOWUP STRATEGIES AFTER RADICAL PROSTATECTOMY: A SURVEY OF AMERICAN UROLOGICAL ASSOCIATION UROLOGISTS 1999 ·The Journal of Urology ·(unknown), John W. Colberg, David K. Ornstein, (unknown), Danny Chan, Katherine S. Virgo, Frank E. Johnson	31
16	Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer 1999 ·British Journal of Urology ·David K. Ornstein, Julia A. Beiser, Gerald L. Andriole	28
17	EVALUATION AND MANAGEMENT OF THE MAN WHO HAS FAILED PRIMARY CURATIVE THERAPY FOR PROSTATE CANCER 1998 ·Urologic Clinics of North America ·David K. Ornstein, (unknown), (unknown), Gerald L. Andriole	25
18	Effect of Canarypox Virus (ALVAC)-Mediated Cytokine Expression on Murine Prostate Tumor Growth 1997 ·JNCI Journal of the National Cancer Institute ·Mutsushi Kawakita, Geetha Rao, Julie Ritchey, David K. Ornstein, M’Liss A. Hudson, (unknown), (unknown), Peter A. Humphrey, James Tartaglia, Enzo Paoletti	51
19	Combined finasteride and flutamide therapy in men with advanced prostate cancer 1996 ·Urology ·David K. Ornstein, Ganesh Rao, (unknown), (unknown), Gerald L. Andriole	68
20	Molecular Characterization, Ultrastructural Localization and Gene Cloning of the Chick Cerebellar Kainate Receptor 1990 ·Advances in experimental medicine and biology ·Vivian I. Teichberg, Nomi Eshhar, (unknown), (unknown), David K. Ornstein, Arturo Ortega, Paul Gregor	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact